pioneer 6 semaglutide Medications like and Tirzepatide are not just for diabetes and weight loss! Major Cardiovascular, Metabolic, and Safety Outcomes

This slow ramp-up of the doses can potentially help reduce side effects moving forward

Some researchers transition to other fat loss peptides or longevity-focused protocols after completing a retatrutide cycle, using the metabolic improvements as a foundation for further optimization

Marangon Junior H, Souza PE, Soares RV, de Andrade BA, de Almeida OP, Horta MC

We need more clinical trials examining the cardiac benefits of SGLT2 inhibitors and GLP-1 agonists for patients prescribed insulin, but with more information on diabetes control and the extent of that benefit provided as the diabetes control is worse. For more information: Joanna Khatib, MBBS , can be reached at [email protected].

Because GLP-1 medications can lead to rapid weight loss, some patients may lose significant lean muscle mass during treatment